A recent study by Joan et al. [23] identified that a unique immune microenvironment profile, characterized by high tumor mutational burden (TMB)/PD-L1 expression and low burden of somatic copy number alterations (SCNAs), can predict long PFS (>18 months). The gene discussed is CD274; the disease is neoplasm.